fqubed

fQubed was a life sciences technology company specializing in high-throughput formulation and process development for the pharmaceutical industry. The company's proprietary "f3" platform enabled the rapid screening and optimization of drug formulations, significantly reducing the time and cost associated with bringing new therapies to market. By utilizing advanced robotics and informatics, fQubed provided pharmaceutical partners with data-driven insights into solubility, stability, and bioavailability. The company's technology was particularly focused on overcoming the challenges of poorly soluble drug candidates. In 2006, fQubed was acquired by NuPathe, a specialty pharmaceutical company, to integrate these formulation capabilities into NuPathe's development of branded products. Following the acquisition, the Bethlehem-based facility continued to operate as a research and development hub for NuPathe until its eventual acquisition by Teva Pharmaceuticals.